Efficacy and safety of first-line cetuximab therapy for older patients (aged ≥ 70 years) with RAS wild-type metastatic colorectal cancer: a nationwide real-world study. - Huang CW; Chen CC; Chang SC; Chang YY; Lin BW; Chen HH; Hsieh YY; Hsu HC; Hsieh MC; Ke TW; Kuan FC; Wu CC; et al. (American journal of cancer research, 2025)